FeesSafety
Pluang+

Herzfeld Credit Income Fund completes tender offer to buy back 5% of shares at 97.5% NAV.

Company Fundamentals
20 Oct 2026, 23:30 WIB
GlobeNewsWire
View Source
Neutral
Herzfeld Credit Income Fund completes tender offer to buy back 5% of shares at 97.5% NAV.

Herzfeld Credit Income Fund, Inc. announced the final results of its tender offer to repurchase up to 5% of its outstanding common shares at 97.5% of the net asset value per share as of October 15, 2026. Although 1,441,647 shares were tendered, the Fund will purchase only 100,886 shares on a pro-rata basis, equating to about 7% of the tendered shares. This move aims to manage share supply and potentially reduce the discount at which shares trade relative to NAV. Shareholders accepted the offer, and the Fund will complete the repurchase promptly.

Herzfeld Credit Income Fund, Inc. announced a tender offer to repurchase up to 5% of its shares at 97.5% of NAV as of October 15, 2026. For readers following Financials-sector US stocks, here is Pluang's market snapshot as of Oct 21, 2026 03:11 WIB: out of 142 priced stocks, 109 rose and 32 fell. Notable moves include Banco Bradesco Sa American Depositary Shares (BBD) up 3.68% at USD 4.08 with 100% buy orders, Avalanche Treasury Corporation Class A Common Stock (AVAT) up 3.36% at USD 1.23, and Oxford Lane Capital Corp (OXLC) down 3.32% at USD 7.29 with 100% buy orders and a typical hold time of 53 days.

More News

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

Global beverage market to reach $2.78T by 2032, driven by nonalcoholic drinks and convenience trends.

The global beverage market is projected to grow from $2.03 trillion in 2026 to $2.78 trillion by 2032, at a CAGR of 5.35%. Growth is fueled by rising demand for nonalcoholic and functional beverages, convenience packaging, and premium products for sp...

Market News
Bullish
2 hours ago
Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

Over 200 GLP-1 and incretin therapies in development are reshaping diabetes and obesity treatment landscapes.

DelveInsight's 2026 report reveals more than 200 GLP-1 receptor agonists and incretin-based therapies are in development by over 180 companies, targeting conditions like type 2 diabetes, obesity, and related metabolic disorders. Key players such as E...

Bullish
3 hours ago
Pyth Network adds real-time NYSE stock data, boosting tokenized stock trading accuracy.

Pyth Network adds real-time NYSE stock data, boosting tokenized stock trading accuracy.

Pyth Network has integrated real-time stock and ETF data from five NYSE exchanges into its marketplace, enhancing its institutional market-data services. This expansion follows its earlier Nasdaq integration, providing developers a unified source for...

Protocol Fundamentals
Bullish
5 hours ago
Innovative Holdings Alliance rebrands as Premergy, shifts focus to battery tech under new ticker PMGY.

Innovative Holdings Alliance rebrands as Premergy, shifts focus to battery tech under new ticker PMGY.

Innovative Holdings Alliance, Inc. has changed its name to Premergy, Inc. and will trade under the new ticker symbol PMGY starting November 12, 2026. This rebranding aligns the company with its focus on advanced battery technology and power-managemen...

Company Fundamentals
Neutral
5 hours ago
AMH declares Q4 2026 dividend of $0.33 per common share, payable Dec 31.

AMH declares Q4 2026 dividend of $0.33 per common share, payable Dec 31.

AMH announced a dividend of $0.33 per common share for Q4 2026, payable in cash on December 31 to shareholders of record as of December 15. Additionally, quarterly distributions were declared for preferred shares: $0.36719 for Series G and $0.39063 f...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App